InspireMD Inc. (OTC:NSPR) launched its MGuard coronary stent system in India.
The Tel Aviv-based firm’s flagship product is the first mesh-based coronary stent system available in the country, the company said.
The CE Mark approved MGuard stent is wrapped with a polymer mesh sleeve designed to protect acute MI patients against embolism. Kirloskar Technologies P. Ltd., which has already closed an initial order for the stent in India, will be InspireMD’s distributor of the product, according to the company.